[5-(4-Fluorobenzyl)-3-(4-pyridinyl)-1H-pyrazol-1-yl]acetic acid
95%
- Product Code: 188395
CAS:
1001383-88-5
| Molecular Weight: | 311.31 g./mol | Molecular Formula: | C₁₇H₁₄FN₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD21606646 | |
| Melting Point: | Boiling Point: | ||
| Density: | 1.30±0.1 g/cm3 (20 ºC 760 Torr) | Storage Condition: | 2-8°C |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell proliferation. Its structure supports binding to ATP sites in enzymes, making it valuable in developing targeted therapies for oncology. Also explored in the design of anti-inflammatory agents due to its ability to modulate signaling pathways. The acetic acid moiety enhances solubility and bioavailability in preclinical drug formulations.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1g | 10-20 days | ฿52,230.00 |
+
-
|
[5-(4-Fluorobenzyl)-3-(4-pyridinyl)-1H-pyrazol-1-yl]acetic acid
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell proliferation. Its structure supports binding to ATP sites in enzymes, making it valuable in developing targeted therapies for oncology. Also explored in the design of anti-inflammatory agents due to its ability to modulate signaling pathways. The acetic acid moiety enhances solubility and bioavailability in preclinical drug formulations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :